Cytogenic investigations in the assessment of response to treatment in neuroblastoma.
Authors:
- M M ReidMRM M Reid
- A D PearsonAPA D Pearson
- E V DavisonEDE V Davison
- A J MalcolmAMA J Malcolm
- A W CraftACA W Craft
Open Access
- 1 November 1987
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 40 (11) , 1334-1336
Abstract
In a patient with stage IV disseminated neuroblastoma treated by chemotherapy extensive cytogenetic investigations were performed on the residual primary tumour and bone marrow immediately before myeloablative treatment and autologous marrow rescue. Two abnormal clones both showing lp+, a characteristic abnormality of neuroblastoma, were detected in cells from the residual primary tumour, providing direct evidence of persisting viable tumour. Such investigations should be a routine part of the assessment of response to treatment in patients with neuroblastoma, and could be extended to others in whom "second look" surgery is performed.Keywords
This publication has 6 references indexed in Scilit:
- Fragile sites and cancer breakpointsCancer Genetics and Cytogenetics, 1984
- Solid tumors of children: Chromosome abnormalities and the development of cancerJournal of Cellular Physiology, 1984
- Chromosome analysis of human neuroblastoma cell line TR14 showing double minutes and an aberration involving chromosome 1Cancer Genetics and Cytogenetics, 1983
- USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERSThe Lancet, 1983
- CYTOGENETIC FEATURES OF HUMAN NEUROBLASTOMAS AND CELL-LINES1981
- EXCLUSION OF CHROMOSOMAL MOSAICISM - TABLES OF 90PERCENT, 95PERCENT, AND 99PERCENT CONFIDENCE-LIMITS AND COMMENTS ON USE1977